AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)

CUSIP: 03152W109

Q3 2020 13F Holders as of 30 Sep 2020

Holder snapshot 7 signals
Share change
-4,011,547
Put/Call ratio
28%
SEC-reported price per share
$14.12
Number of holders
241
Value change
-$60,291,396
Number of buys
113
Open additional details 1 more signal available
Number of sells
111
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
316,644,581

Security key

03152W109

Report period

Q3 2020

Institutions

241

Top holders

10

Ownership snapshot

Top reported holders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F Highest disclosed value: $379,750,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PERCEPTIVE ADVISORS LLC has the largest disclosed position value at $379.75M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
PERCEPTIVE ADVISORS LLC $379.75M
Redmile Group, LLC $376.17M
VANGUARD GROUP INC $363.62M
BlackRock Finance, Inc. $335.62M
Janus Henderson Group Ltd. $177.85M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$379,750,000
25,182,364 shares
— 30 Jun 2020
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$376,166,000
24,944,695 shares
— 30 Jun 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$363,620,000
24,112,736 shares
— 30 Jun 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$335,618,000
22,255,818 shares
— 30 Jun 2020
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$177,849,000
11,793,759 shares
— 30 Jun 2020
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$165,880,000
11,000,000 shares
— 30 Jun 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
241
Shares
277,950,423
Rows available
241
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
217
Q3 2020 holders
241
Holder diff
24
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 value Q3 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .